Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

miR-29 is a key factor that accelerates aging.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Nanotechnology shows promise for better drug delivery and cancer treatment.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Oestrogens are key for bone growth during puberty in both boys and girls.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Minoxidil promotes hair regrowth in early baldness stages and prevents baldness in non-bald scalps.